India-based genomics diagnostic test provider MedGenome has attracted $10m from financial services group HDFC Bank to close its series C round at $40m, Inc42 has reported.

Two HDFC subsidiaries, insurer HDFC Life and HDFC Asset Management, joined their parent company in adding to the $30m series C first tranche MedGenome closed in August 2017.

Investment holding company Sofina and venture capital firm Sequoia Capital co-led the first tranche, with contributions from Zodius Capital and individual investors Kris Gopalakrishnan and Lakshmi…